DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Betoptic (Betaxolol Hydrochloride Ophthalmic) - Published Studies


Betoptic Related Published Studies

Well-designed clinical trials related to Betoptic (Betaxolol Ophthalmic)

Prevention of perioperative atrial fibrillation with betablockers in coronary surgery: betaxolol versus metoprolol. [2009.07]

Efficacy of brinzolamide and levobetaxolol in pediatric glaucomas: a randomized clinical trial. [2008.06]

Penetration of betaxolol HCL ionic suspension 0.25% and betaxolol HCL solution 0.50% into the aqueous humor. [2007.05]

Compliance, clinical outcome, and quality of life of patients with stable angina pectoris receiving once-daily betaxolol versus twice daily metoprolol: a randomized controlled trial. [2007]

Betaxolol is equivalent to carvedilol in patients with heart failure NYHA II or III: result of a randomized multicenter trial (BETACAR Trial). [2006.11.10]

Effects of latanoprost and betaxolol on cardiovascular and respiratory status of newly diagnosed glaucoma patients. [2006]

Effect of betaxolol hydrochloride on heart rate variability indices during exercise stress testing in patients with hypertension. [2005.10]

The comparative cardiovascular, pulmonary, ocular blood flow, and ocular hypotensive effects of topical travoprost, bimatoprost, brimonidine, and betaxolol. [2004.08]

Effects of betaxolol and latanoprost on ocular blood flow and visual fields in patients with primary open-angle glaucoma. [2004.05]

Randomized clinical trial of topical betaxolol for persistent macular edema after vitrectomy and epiretinal membrane removal. [2003.08]

Changing antiglaucoma therapy from timolol to betaxolol: effect on ocular blood flow. [2003.07]

Influence of topical betaxolol and timolol on visual field in Japanese open-angle glaucoma patients. [2003.03]

Results of the betaxolol versus placebo treatment trial in ocular hypertension. [2003.03]

Progression of retinal nerve fibre layer damage in betaxolol- and timolol-treated glaucoma patients. [2002.10]

A double-masked randomized comparison of the efficacy and safety of unoprostone with timolol and betaxolol in patients with primary open-angle glaucoma including pseudoexfoliation glaucoma or ocular hypertension. 6 month data. [2002.01]

The one-month effects of topical betaxolol, dorzolamide and apraclonidine on ocular blood flow velocities in patients with newly diagnosed primary open-angle glaucoma. [2001.09]

Comparison of the clinical success and quality-of-life impact of brimonidine 0.2% and betaxolol 0.25 % suspension in patients with elevated intraocular pressure. [2001.07]

Comparison of the clinical success rates and quality of life effects of brimonidine tartrate 0.2% and betaxolol 0.25% suspension in patients with open-angle glaucoma and ocular hypertension. Brimonidine Outcomes Study Group II. [2000.10]

Comparison of the efficacy of betaxolol-brinzolamide and timolol-dorzolamide as suppressors of aqueous humor flow in human subjects. [2000.02]

The lack of efficacy of topical beta-blockers, timolol and betaxolol on intraocular pressure in Nigerian healthy volunteers. [1999.12]

Betaxolol versus carvedilol in chronic heart failure (BETACAR study). Rationale and design. [1999.04]

Effect of betaxolol on the hemodynamic, gas exchange, and cardiac output response to exercise in chronic atrial fibrillation. [1999.04]

The favorable effect of topical betaxolol and timolol on glaucomatous visual fields: a 2-year follow-up study. [1999.02]

Influence of betaxolol and timolol on the venous tone in glaucoma patients. [1999]

A double-masked, randomized, 1-year study comparing the corneal effects of dorzolamide, timolol, and betaxolol. Dorzolamide Corneal Effects Study Group. [1998.08]

A comparison of the effects of betaxolol, timolol, and pilocarpine on visual function in patients with open-angle glaucoma. [1998.08]

Aqueous humour concentration and the intraocular pressure-lowering effect of topical betaxolol before cataract surgery. [1998.07]

Effect of betaxolol on primary open-angle glaucoma and normal-tension glaucoma patients. [1998.06]

Comparison of the efficacy and safety of 2% dorzolamide and 0.5% betaxolol in the treatment of elevated intraocular pressure. Dorzolamide Comparison Study Group. [1998.05]

The effect of betaxolol on ocular blood flow and visual fields in patients with normotension glaucoma. [1998.04]

Randomised, controlled trial of spirometric changes in elderly people receiving timolol or betaxolol as initial treatment for glaucoma. [1998.02]

Comparison of short- and long-term effects of betaxolol and timolol on human retinal circulation. [1998]

[Effect of betaxolol on blood pressure and heart rate in mild to moderate hypertension] [1997.10.19]

A comparison of the safety and efficacy of twice daily brimonidine 0.2% versus betaxolol 0.25% in subjects with elevated intraocular pressure. The Brimonidine Study Group III. [1996.11]

Ocular hypotensive efficacy and safety of a combined formulation of betaxolol and pilocarpine. [1996]

Comparative study of efficacy and safety of low-dose diltiazem or betaxolol in combination with digoxin to control ventricular rate in chronic atrial fibrillation: randomized crossover study. [1995.11.24]

A double-masked, randomized 1-year study comparing dorzolamide (Trusopt), timolol, and betaxolol. International Dorzolamide Study Group. [1995.08]

Retrobulbar arterial hemodynamic effects of betaxolol and timolol in normal-tension glaucoma. [1995.08]

Differences in the longterm effect of timolol and betaxolol on the pulsatile ocular blood flow. [1994.05]

Safety and compatibility of betaxolol hydrochloride combined with diltiazem or nifedipine therapy in stable angina pectoris. [1994.02.01]

Betaxolol in the treatment of stable angina pectoris. [1994]

Effect of betaxolol on the retinal circulation in eyes with ocular hypertension: a pilot study. [1994]

Beta 1- and beta 2-antagonist activity of topically applied betaxolol and timolol in the systemic circulation. [1993.10]

A double-masked comparison of betaxolol and dipivefrin for the treatment of increased intraocular pressure. [1993.09.15]

The effect of betaxolol and timolol on postoperative intraocular pressure. [1993.08]

Plasma and aqueous humour concentrations and systemic effects of topical betaxolol and timolol in man. [1993.04]

[Clinical evaluation of betaxolol in ophthalmic suspension with or without preservative agent in patients with glaucoma or ocular hypertension] [1993]

Randomized, double-blind, crossover, placebo-controlled comparison of propranolol and betaxolol in the treatment of neuroleptic-induced akathisia. [1992.05]

Dose-dependent effects of betaxolol in hypertension: a double-blind, multicenter study. [1992.04]

Comparison of the postoperative intraocular pressure with Betagan, Betoptic, Timoptic, Iopidine, Diamox, Pilopine Gel, and Miostat. [1992.01]

Influence of betaxolol and timolol on the visual fields of patients with glaucoma. [1991.12.15]

Impact of diagnosis and treatment of hypertension on quality of life: a double-blind, randomized, placebo-controlled, cross-over study of betaxolol. [1991.11]

[Effect of betaxolol and timolol on visual fields in glaucoma patients] [1991.05]

The effects of time and dose on the relative beta 1- and beta 2-adrenoceptor antagonism of betaxolol and atenolol. [1991.02]

Population dose versus response of betaxolol and atenolol: a comparison of potency and variability. [1991.01]

Betaxolol and glucose-insulin relationships: studies in normal subjects taking glibenclamide or metformin. [1990.11]

[A new topical carbonic anhydrase inhibitor (MK-927). Tolerance comparison with betaxolol in healthy probands] [1990.09]

A double-masked three-month comparison between 0.25% betaxolol suspension and 0.5% betaxolol ophthalmic solution. [1990.08.15]

Effects of topical timolol (0.5%) and betaxolol (0.5%) on corneal sensitivity. [1990.07]

A dose-ranging study to evaluate the beta-adrenoceptor selectivity of single doses of betaxolol. [1990.07]

Double-blind comparison of once daily betaxolol versus propranolol four times daily in stable angina pectoris. Betaxolol Investigators Group. [1990.03.01]

Comparison of the antihypertensive effects of betaxolol and chlorthalidone as monotherapy and in combination. [1989.11]

The significance of reactions to betaxolol reported by patients. [1989.11]

Steady-state fluctuation and variability of betaxolol and atenolol plasma levels. [1989.09]

Changing therapy from timolol to betaxolol. Effect on intraocular pressure in selected patients with glaucoma. Timolol-Betaxolol Study Group. [1989.09]

Treatment of severe hypertension with atenolol and betaxolol with once-daily regimens. Hemodynamic aspects. [1989.09]

A comparison of the efficacy of betaxolol and timolol in ocular hypertension with or without adrenaline. [1989.05]

[The effect of the beta 1 selective beta blocker, betaxolol, on metabolism in type II diabetics] [1989.05]

Comparison of topical timolol vs betaxolol on cardiopulmonary exercise performance in healthy volunteers. [1988.08]

Levobunolol and betaxolol. A double-masked controlled comparison of efficacy and safety in patients with elevated intraocular pressure. [1988.06]

Comparison of the antihypertensive effects of betaxolol to atenolol. [1988.04.01]

A comparison of betaxolol and timolol in open angle glaucoma and ocular hypertension. [1988.04]

Comparison of betaxolol with verapamil in hypertensive patients: discrepancy between office and ambulatory blood pressures. [1988.03]

[Comparative pharmacoclinical study of 2 beta-blockers: atenolol and betaxolol in slight-to-moderate arterial hypertension] [1987.11]

[Treatment with betaxolol and placebo eyedrops in patients with glaucoma and reactive airway diseases] [1987.09]

Effects of betaxolol on heart rate in patients with a recent transmural myocardial infarction. [1987]

Well-designed clinical trials possibly related to Betoptic (Betaxolol Ophthalmic)

The ability of short-wavelength automated perimetry to predict conversion to glaucoma. [2010.01]

Disc hemorrhages and treatment in the early manifest glaucoma trial. [2008.11]

Predictors of long-term progression in the early manifest glaucoma trial. [2007.11]

Fluctuation of intraocular pressure and glaucoma progression in the early manifest glaucoma trial. [2007.02]

Treatment and vision-related quality of life in the early manifest glaucoma trial. [2005.09]

Low incidence of iris pigmentation and eyelash changes in 2 randomized clinical trials with unoprostone isopropyl 0.15%. [2004.08]

[Serum lipid profile in non-exudative AMD patients treated with locally administrated beta-blockers] [2004]

[Structural and immunohistochemical changes of conjunctiva induced by topical glaucoma medication] [2004]

Effect of laser in situ keratomileusis on optic nerve head topography and retinal nerve fiber layer thickness. [2003.12]

Measuring visual field progression in the Early Manifest Glaucoma Trial. [2003.06]

Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial. [2003.01]

Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. [2002.10]

Sympathetic control of accommodation: evidence for inter-subject variation. [2002.09]

Effect of beta-adrenoceptor antagonists on autonomic control of ciliary smooth muscle. [2002.09]

A 7 year prospective comparative study of three topical beta blockers in the management of primary open angle glaucoma. [2001.08]

Clinical and economic impact of new trends in glaucoma treatment. [2001.07.26]

The effects of beta-blockers on ocular blood flow in patients with primary open angle glaucoma: a color Doppler imaging study. [2001.01]

Early Manifest Glaucoma Trial: design and baseline data. [1999.11]

Modulation of Heidelberg Retinal Flowmeter parameter flow at the papilla of healthy subjects: effect of carbogen, oxygen, high intraocular pressure, and beta-blockers. [1999.06]

The acute effect of topical beta-adrenoreceptor blocking agents on retinal and optic nerve head circulation. [1998.02]

Effects of topical adrenergic agents on tissue circulation in rabbit and human optic nerve head evaluated with laser speckle tissue circulation analyzer. [1997.11]

Topical beta-blockade with intrinsic sympathomimetic activity offers no advantage for the respiratory and cardiovascular function of elderly people. [1996.11]

A clinical trial of MK-507, Trusopt, for raised intraocular pressure--the Australian experience. [1996.05]

A controlled clinical trial of dorzolamide: a single-centre subset of a multicentre study. [1996.02]

Avoiding unsuspected respiratory side-effects of topical timolol with cardioselective or sympathomimetic agents. [1995.06.24]

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017